ScoreWhy is Zhejiang Dayang Biotech Group Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 14.97% and Operating profit at 10.10% over the last 5 years
2
The company has declared Positive results for the last 5 consecutive quarters
- NET SALES(HY) At CNY 576.26 MM has Grown at 18.74%
- ROCE(HY) Highest at 9.02%
- RAW MATERIAL COST(Y) Fallen by -12.69% (YoY)
3
With ROE of 8.78%, it has a attractive valuation with a 1.52 Price to Book Value
- Over the past year, while the stock has generated a return of 10.07%, its profits have risen by 35.9% ; the PEG ratio of the company is 0.5
- At the current price, the company has a high dividend yield of 1.1
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Zhejiang Dayang Biotech Group Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Chemicals & Petrochemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Zhejiang Dayang Biotech Group Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Zhejiang Dayang Biotech Group Co., Ltd.
-17.69%
0.95
44.46%
China Shanghai Composite
3.23%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
14.97%
EBIT Growth (5y)
10.10%
EBIT to Interest (avg)
10.50
Debt to EBITDA (avg)
0.20
Net Debt to Equity (avg)
0.04
Sales to Capital Employed (avg)
0.64
Tax Ratio
8.15%
Dividend Payout Ratio
44.87%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.97%
ROE (avg)
7.03%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
1.87
EV to EBIT
26.52
EV to EBITDA
18.52
EV to Capital Employed
1.83
EV to Sales
2.09
PEG Ratio
0.59
Dividend Yield
1.54%
ROCE (Latest)
6.90%
ROE (Latest)
8.78%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
ROCE(HY)
Highest at 9.49%
DEBTORS TURNOVER RATIO(HY)
Highest at 7.47 times
DIVIDEND PER SHARE(HY)
Highest at CNY 7.47
-7What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 100.75 MM
RAW MATERIAL COST(Y)
Grown by 9.27% (YoY
DEBT-EQUITY RATIO
(HY)
Highest at 15.81 %
Here's what is working for Zhejiang Dayang Biotech Group Co., Ltd.
Debtors Turnover Ratio
Highest at 7.47 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Dividend per share
Highest at CNY 7.47
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (CNY)
Here's what is not working for Zhejiang Dayang Biotech Group Co., Ltd.
Operating Cash Flow
Lowest at CNY 100.75 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Debt-Equity Ratio
Highest at 15.81 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 9.27% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
